Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 161

Results For "inter"

3199 News Found

Sun Pharma joins hands with WOTR to create water harvesting capacity in Maharashtra
News | November 13, 2023

Sun Pharma joins hands with WOTR to create water harvesting capacity in Maharashtra

This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change


Aurobindo Pharma posts Q2 FY 24 up 84% at Rs. 752 Cr
News | November 10, 2023

Aurobindo Pharma posts Q2 FY 24 up 84% at Rs. 752 Cr

The company reported net profit after share of profit/loss of JV and minority interest at Rs. 752 crore vs. Rs. 409 crore in Q2FY23


SMS Pharmaceuticals reports robust Q2FY24 operational performance
News | November 10, 2023

SMS Pharmaceuticals reports robust Q2FY24 operational performance

Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore


Bayer posts Q3 2023 Group sales Euro 10.34 billion
News | November 09, 2023

Bayer posts Q3 2023 Group sales Euro 10.34 billion

We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”


Aster DM Healthcare launches a 506-bed multi-specialty hospital in Bengaluru
Healthcare | November 02, 2023

Aster DM Healthcare launches a 506-bed multi-specialty hospital in Bengaluru

Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India


Indian Health Minister Dr. Mandaviya addresses 76th session of the WHO Regional Committee for South-East Asia
Policy | October 31, 2023

Indian Health Minister Dr. Mandaviya addresses 76th session of the WHO Regional Committee for South-East Asia

India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind


Alkem ‘Healthy Lungs' initiative aims to clear the air
News | October 31, 2023

Alkem ‘Healthy Lungs' initiative aims to clear the air

The initiative will focus on advocating for cleaner air


Pfizer and BioNTech announce data for mRNA-based vaccine program for influenza and COVID-19
News | October 30, 2023

Pfizer and BioNTech announce data for mRNA-based vaccine program for influenza and COVID-19

The companies plan to start a pivotal Phase 3 trial in the coming months


Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-mutant advanced non-small cell lung cancer
Drug Approval | October 26, 2023

Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-mutant advanced non-small cell lung cancer

Approval based on DESTINY-Lung02 results where AstraZeneca and Daiichi Sankyo’s Enhertu demonstrated a confirmed objective response rate of 49% and median duration of response of 16.8 months in previously treated patients


Venus Remedies earns REO Certification from CII for second consecutive year
News | October 26, 2023

Venus Remedies earns REO Certification from CII for second consecutive year

The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)